Malignant Bone Marrow Neoplasm — Trials

Malignant Bone Marrow Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

4,612 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,035
Recruiting: 592
Ph III recruiting: 61
Growth YoY: +8.1%
Industry share: 22%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 37.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (801)

clinicaltrialsPublishedShowing 401–450 of 709 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06859424	A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation(ACCELERATE)	recruiting	Phase 2	358	Center for International Blood and Marrow Transplant ResearchNETWORK	1	Mar 17, 2026	clinicaltrials
NCT07396480	Fludarabine Plus Melphalan Versus Addition of Venetoclax to Fludarabine/Melphalan Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in AML/MDS Patients Aged > 50 Years: a Multicenter, Randomized, Phase 3 Trial	recruiting	Phase 3